Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data
Head and neck squamous cell carcinoma (HNSCC) is a disease with heterogeneous clinical behavior and response to therapies. Despite the introduction of multimodality treatment, 40–50% of patients with advanced disease recur. Therefore, there is an urgent need to improve the classification beyond the...
Main Authors: | De Cecco, Loris, Nicolau, Monica, Giannoccaro, Marco, Daidone, Maria Grazia, Bossi, Paolo, Locati, Laura, Licitra, Lisa, Canevari, Silvana |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496244/ |
Similar Items
-
Correction: Comparison of Microarray Platforms for Measuring Differential MicroRNA Expression in Paired Normal/Cancer Colon Tissues
by: Callari, Maurizio, et al.
Published: (2013) -
Comparison of Microarray Platforms for Measuring Differential MicroRNA Expression in Paired Normal/Cancer Colon Tissues
by: Callari, Maurizio, et al.
Published: (2012) -
Comment on ‘Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base'
by: Bossi, Paolo, et al.
Published: (2015) -
Molecular biology of head and neck cancers
by: Deepa Philip, et al.
Published: (2016-01-01) -
Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy
by: Machiels, Jean-Pascal H, et al.
Published: (2014)